Human Milk Oligosaccharides Market 2021 – Global Industry Market Report 2027

 Market Highlights

The Global Human Milk Oligosaccharides Market is Expected to Register a CAGR of 27.06% During the Forecast Period with a market value of USD 110.03 Million in 2018.

The role of breast milk in infant nutrition is of paramount importance as it ensures health and nourishment. However, in many cases, breastfeeding is not an option due to factors such as genetic defects, terminal diseases, and infections. In such cases, HMOs and associated functional foods play an important role in providing the required nutrition and immunity. HMOs play a major role in ensuring immunity more than nourishment. They are undigested and thus act as preferred feed for the good bacteria in the gut. This boosts the immune system, especially in infants, which helps fight viruses and infectious bacteria.

Key Players

Market Research Future (MRFR) recognizes DuPont Nutrition & Health (Denmark), Abbott (US), BASF SE (Germany), Glycom (Denmark), Dextra Laboratories Limited (UK), Elicityl S.A. (France), Glycosyn LLC (US), Inbiose (Belgium), Jennewein Biotechnologie GmbH (Germany), Medolac Laboratories (US), Nestlé Health Science (Switzerland), and ZuChem (US) as the key players in the global human milk oligosaccharides market.

Access Full Report Details and Order this Premium Report @  https://www.marketresearchfuture.com/reports/human-milk-oligosaccharides-market-7843

Market Segmentation

The global human milk oligosaccharides market is segmented on the basis of type, application, and region.

Based on type, the global human milk oligosaccharides market has been segregated into neutral and acidic. Application-wise, the market has been segmented into food industry and laboratory research.

Regional Analysis

The global human milk oligosaccharides market has been segmented, on the basis of region, into North America, Europe, China, and Japan.

North America accounted for the largest share of the global human milk oligosaccharides market in 2018 and is expected to maintain its dominance throughout the forecast period. This can be attributed to the high consumption of infant formula in the region and increasing approval of new HMO products.

The European human milk oligosaccharides market was the second largest in 2018. In the UK, the rate of breastfeeding is the lowest in the world, which is a major determinant driving the regional market growth. Moreover, the approval of new and enhanced HMOs in the region is also contributing to the growth of the European human milk oligosaccharides market.

China is expected to be the fastest-growing market for HMOs during the forecast period owing to the increasing demand for HMO-based infant formula in the country.

 

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details

Comments

Popular posts from this blog

Global Organic Fertilizers Market Report 2020 Share, Size, Trend, Market Analysis and Forecast to 2027

North America Cannabis Market - Industry Growth and Forecast – 2024

Healthcare RFID Market Report Predicts Impressive Growth by 2027 Just Published